What is SDGR's market cap?

$2.13B, based on the Nov 4 close of $28.52.

Does Schrodinger pay a dividend?

No regular cash dividend has been paid in the last year.

How much of SDGR is sold short?

10.4M shares, 19.8% of float, as of Oct 15, 2026.

What sector is SDGR in?

Healthcare, in the Pharmaceuticals industry.

NASDAQ · SDGRHealthcarePharmaceuticals

Schrodinger, Inc. Common Stock (SDGR)

$28.52+4.93%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$28.52▲ 42.67% in range

Nov 4, 2025Low $11.07 · High $32.60Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Schrodinger closed at $28.52 on Nov 4, up 4.93%, 12.5% below its 52-week closing high. Volume of 1.9M shares was 0.99× its 20-day average (close to normal).

Split-adjusted performance: -1.3% over one month, +119.7% over six months, +38.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $58.89M, up 7.5% from a year earlier, with a net margin of 10.1%.

Short interest was 10.4M shares at the Oct 15 settlement, up 2.7% from the prior report (19.8% of float, 3.4 days to cover).

Market cap$2.13B74.8M shares

Revenue · quarter$58.9M+7.5% YoY

Diluted EPS$0.08—

P/E · TTM—P/S 8.2×

Net margin10.1%Gross 55.1%

Dividend yieldNone

52-week range11.07 – 32.60−12.5% from high

Volume1.9M0.99× 20-day avg

Volatility · 60d94.5%Annualised

Short % of float19.8%3.4 days to cover

Net cash$413.7MCash $413.7M

Next earnings—Not scheduled

Split-adjusted performance

1W −7.6%1M −1.3%3M +60.1%6M +119.7%YTD +59.5%1Y +38.8%3Y +31.9%5Y −46.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum99

Revenue growth52

Net margin79

Value (low P/E)—

Size82

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short10.4M+2.7% vs prior

Days to cover3.4Settled Oct 15

% of float19.8%

Short vol. 10d50.3%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
SDGRSchrodinger	$28.52	+4.93%	+119.7%	+7.5%	10.1%	—	$2.13B
PRGOPERRIGO	$15.83	+0.83%	+29.1%	−3.2%	7.3%	—	$2.20B	Compare
TRAXFirst Tracks Biotherapeutics	$49.04	+5.83%	—	—	—	—	$2.06B	Compare
ZYMEZymeworks	$30.94	+2.69%	+12.1%	−90.6%	−980.8%	—	$2.22B	Compare
TRLVTrulieve Cannabis	$11.60	+0.52%	—	—	−149.8%	—	$2.23B	Compare
SEPNSepterna	$47.88	+9.57%	+93.8%	+22375.6%	−48.7%	—	$2.23B	Compare
SRPTSarepta Therapeutics,	$18.99	+2.43%	−17.5%	−34.3%	−1.2%	—	$2.01B	Compare
HRMYHarmony Biosciences Holdings	$34.42	−7.04%	+5.0%	+30.3%	28.9%	11.1	$2.00B	Compare
TRVITrevi Therapeutics	$13.99	+0.90%	−1.9%	—	—	—	$1.99B	Compare

News about Schrodinger

All news →

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Beats Revenue EstimatesZacks Investment Research · 7h ago▲ Positive Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?Zacks Investment Research · Oct 6, 2026▲ Positive

Quick answers

What does Schrodinger do?: Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules.
What is SDGR's market cap?: $2.13B, based on the Nov 4 close of $28.52.
Does Schrodinger pay a dividend?: No regular cash dividend has been paid in the last year.
How much of SDGR is sold short?: 10.4M shares, 19.8% of float, as of Oct 15, 2026.
What sector is SDGR in?: Healthcare, in the Pharmaceuticals industry.

About Schrodinger

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

HQ: New York, NY850 employeesListed Feb 6, 2020schrodinger.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology